Exclusives | Americas

Kimberly-Clark prepares asset sales to win EU nod for Kenvue deal, sources say

14 September 2026, 12:40 pm

1 min read

Kimberly Clark and Kenvue logos are seen in this illustration taken, September 13, 2026. REUTERS/Dado Ruvic/Illustration

Kimberly-Clark is preparing concessions to address EU antitrust concerns about its bid for Tylenol maker Kenvue that could help it win approval for the $40 billion deal after a preliminary review, people familiar with the matter said. Kimberly-Clark shares gained as much as 2.7% in early trade and Kenvue 2.2% on the Reuters report.